Oncopeptides AB
Oncopeptides is a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases. The company uses its proprietary PDC platform to develop peptide-drug ...
Oncopeptides AB's Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Stockholm, Sweden
Website
Founded Year
2000
Headcount
11 - 50
Specialties
phase 2OPD5EMDMultiple MyelomaYgaloPlasma Cell MyelomaOrphan DrugRelapsed & Relapsed-Refractory Multiple Myelomapeptidase potentiatedanti-angiogeniccytotoxicityalkylationpeptidase targetingPhase IIIefficacy studiesoncologyPhase IIpeptide conjugated alkylatorphase 3phase 1melflufenRRMMpeptide-drug conjugatemelphalan flufenamide
Oncopeptides AB's Competitors
Sercona GmbH
Germany
NEW Life Medical Clinic
GPrX Data
Cambridge, England, United Kingdom
RenaClinical
United Kingdom
ADHD Medication Calculator/Converter
Baltimore, Maryland, United States
Employee Insights
Employee Function
Employee Location
Oncopeptides AB's Top Employees
Sara Svärdgren
Human Resources Business Partner
Mark Biddle
Head of Global IT / CIO
Eva Nordström
Chief Operating Officer
Jakob Lindberg
CEO
Klaas Bakker
Executive Vice President AND Chief Medical Officer
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding Oncopeptides AB
Where is Oncopeptides AB's headquarter located?
Oncopeptides AB's headquarter are located at Sweden.
How many employees does Oncopeptides AB have?
Oncopeptides AB has 11 - 50 employees.
What is Oncopeptides AB's official website?
Oncopeptides AB's official website is http://www.oncopeptides.com
What industry does Oncopeptides AB belong to?
Oncopeptides AB is in the industry of Pharmaceutical Manufacturing
What does Oncopeptides AB do?
Oncopeptides is a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases. The company uses its proprietary PDC platform to develop peptide-drug ...
What specialty does Oncopeptides AB have?
phase 2OPD5EMDMultiple MyelomaYgaloPlasma Cell MyelomaOrphan DrugRelapsed & Relapsed-Refractory Multiple Myelomapeptidase potentiatedanti-angiogeniccytotoxicityalkylationpeptidase targetingPhase IIIefficacy studiesoncologyPhase IIpeptide conjugated alkylatorphase 3phase 1melflufenRRMMpeptide-drug conjugatemelphalan flufenamide
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
